Clinical trial NCT05684354: Patient Reported Outcome (PRO) in CARDiac Surgery.
Official title: Validation of the Quality of Recovery-15 Score in Cardiac Surgery: The PROCARDS Study
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Cardiac Surgery
Keywords: cardiac
surgery
postoperative care
Lead sponsor: Rennes University Hospital
Sponsor class: OTHER
First posted: 2023-01-13
Enrollment: 156
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Adults patients scheduled for cardiac surgery under CPB including valve surgery, coronary artery bypass, ascending aorta surgery, combined procedure, and had given oral informed consent. Adults subject to legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty, patients unable to complete the questionnaire independently (cognitive deficit or poor French comprehension) and pregnant or breastfeeding women were not included

Brief summary: The use of Patient Reported Outcomes (PROs) in anaesthesia provides a measure of the patient's quality of postoperative recovery based on his/her own experience. The Quality-Of-Recovery-15 (QoR-15) is a widely used questionnaire which has never been validated in cardiac surgery patients.

This study aimed at validating the French version of the QoR-15 scale in a cohort of cardiac surgical patients. The QoR-15 scale would have similar psychometric properties and interpretability in assessing postoperative recovery in this population than in general surgery patients.

Detailed description: The French version of the QoR-15 scale as validated by Demumieux et al was used in this study. Eligible patients were given oral and written information the day before or the morning before surgery. After patient agreed to participate, the first QoR-15 scale was distributed by one of the investigators. The patient filled in the questionnaire alone or could be helped by one of the investigators in case of questions or difficulties.

The second QoR-15 scale was distributed the day before or the day of discharge from the hospital and at the same time the patient was asked to rate his global recovery on a visual analog scale (VAS) graduated from 0 to 100 with 0 being the worst recovery and 100 the best recovery.

Patient demographic characteristics were collected including age, sex, body mass index (BMI), American Society of Anesthesiologists (ASA) physical status score, preoperative status of diabetes, hypertension, smoking status. Following perioperative data were recorded: type of surgery, duration of CPB, need for cardiac pacing or dobutamine support at the end of surgery, number of pleural and mediastinal chest tubes.

Postoperative complications were also recorded: surgical revision, atrial fibrillation requiring antiarrhythmic medication or anticoagulation, pulmonary oedema requiring depletion, drained pleural effusion, drained pneumothorax, radiological atelectasis, radiologic pneumonia, stroke with radiological diagnosis, sepsis as defined by Third International Consensus Definitions for Sepsis and Septic Shock \[Sepsis-3\], Heparin-induced thrombocytopenia (HIT) documented by Serotonin release assay test. Total dose of morphine used in ICU, length of stay (LOS) in ICU and hospital, duration of surgical drains and mortality at day 28 were also assessed.

Statistical analysis Sample size was The sample size was estimated at 150 patients and based on previous published studies(7,8) and guidelines recommending at least 10 subjects per item on the instrument scale(15). Data were reported as mean, median (inter-quartile range), or number (percentage) as appropriate. Correlations were calculated with Pearson correlation coefficient for Gaussian data or with Spearman correlation coefficient for non-Gaussian data. Factors associated with the QOR-15 score were searched by Analysis of Variance (ANOVA) for qualitative parameters and by linear regression for quantitative parameters. The null hypothesis was rejected if two-tailed P-value was inferior to 0.05

Eligibility criteria: Inclusion criteria:

* Patients over 18 years old
* Hospitalized for planned cardiac surgery among: coronary artery bypass grafting, valve plasty, valve replacement or ascending aortic surgery
* Patient not opposing his participation in the research

Non-inclusion criteria:

* Adults subject to legal protection (safeguard of justice, curatorship, guardianship)
* Persons deprived of liberty
* Patient unable to complete the questionnaire independently (cognitive deficit or patient who does not speak French)
* Pregnant or breastfeeding women

Primary outcomes:
measure: Assess the validity of QoR-15 in the post-operative period of cardiac surgery
timeFrame: Day 5
Secondary outcomes:
measure: Assess the Reliability of QoR-15 in the post-operative period of cardiac surgery
timeFrame: Day 5
measure: Assess the Responsiveness of QoR-15 in the post-operative period of cardiac surgery
timeFrame: Day 5
measure: Assess the Feasibility of QoR-15 in the post-operative period of cardiac surgery
timeFrame: Day 5
Other outcomes:
Locations:
city: Rennes
country: France
facility: Rennes University Hospital
Study officials:
affiliation: Rennes University Hospital
name: Grégoire LE GAC
role: PRINCIPAL_INVESTIGATOR
References: